AI
Combining real world evidence with artificial intelligence may improve visibility of treatment options for oncologists
Written by Watson Health | AI, Blog Post, Care Management...
With an impending shortage of oncologists, an exponentially growing body of literature, and a steady stream of new cancer cases, it’s no surprise that one study found significant cancer health disparities in the US. ...read more
How Watson is helping clinicians and cancer centers to identify more patients for clinical trials
Written by Watson Health | AI, Oncology & Genomics
IBM Watson® for Clinical Trial Matching uses artificial intelligence (AI) and natural language processing technology to help cancer centers identify potential candidates for trials and help clinicians find potential clinical trials for their patients. ...read more
No lazy summers for Watson Health: heavy on ‘a’ – action
Written by Watson Health | AI, Blog Post, Life Sciences
Personal values. Commercial pressures. These are forces that shape our jobs every day, especially for leaders in the life sciences. As individuals, we want to solve urgent problems that touch us deeply. As professionals representing growing businesses, we act on our beliefs best when they align with distinct market opportunities. The oft heard slogan of ...read more
Watson Health: Setting the Record Straight
Written by Dr. John E. Kelly III | AI, Blog Post, Oncology & Genomics
We at IBM have a lot to be proud of, including our pioneering work with Watson Health. Unfortunately, some media reports, including an August 11th story published by The Wall Street Journal, distort and ignore facts when suggesting IBM has not made “enough” progress on bringing the benefits of AI to healthcare. ...read more
Watson Health is committed to using AI to tackle major healthcare challenges
Written by Deborah DiSanzo | AI, Blog Post, Oncology & Genomics
I would like to provide an update on Watson Health and address a few misperceptions. If you only read certain media reports recently, you would have an incomplete and inaccurate perspective, especially as it relates to our Watson for Oncology product. ...read more